This site is intended for Healthcare Professionals only

obesity

diabetes-injections-summary

NHS diabetes budget soars as Mounjaro spend up 340-fold

Mounjaro 'emerges as new cost driver' in latest NHSBSA annual report

21 Aug 2025 , 1 Min Article

obesity-summary

NHS plans to give Mounjaro to 250k patients over three years to tackle obesity

NICE consults on proposals to roll out GLP-1 receptor agonist to critical target groups

08 Oct 2024 , 1 Min Article

semaglutide-summary

Off-label use of diabetes drugs to drive ‘critical’ shortages until mid-2024, says MHRA

No new patients to be started on GLP-1 receptor agonists, says MHRA in 'critical' alert

19 Jul 2023 , 1 Min Article

Change privacy settings